FDA
-
-
-
-
-
-
-
TCBP Announces MHRA Acceptance of Amendment for ACHIEVE UK Trial
-
-
-
-
-
-
-
TC BioPharm Announces Submission of Investigational New Drug (IND) Application to U.S. FDA for Treatment of Relapse/Refractory AML
-
-
-
-
-
-
-
TC BioPharm Announces Hiring of Chief Clinical Officer Bree Harlin to Lead Global Clinical Division
-
-
-
-
-
-
-
TC BioPharm (Holdings) Limited (TCBP) Files ADS IPO Registration Statement
322,214 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

